Navigation Links
reco jeans Supports Children With Rare Diseases
Date:2/23/2010

Company Partners with the Global Genes Project to Create Unique Blue Jeans Ribbon from Recycled Denim Material for Spring/Summer 2010

NEW YORK, Feb. 23 /PRNewswire-USNewswire/ -- reco® jeans (www.recojeans.com), the leading manufacturer of true recycled denim jeans, today announced the company will create a special denim ribbon in support of the Global Genes Project (www.globalgenesproject.org), an initiative designed to raise awareness about the prevalence of rare diseases that afflict millions of children worldwide.

Using the official Global Genes Project blue jeans ribbon as inspiration, reco® jeans fashion designers will create a blue jeans ribbon from the company's recycled denim material.  reco® jeans recycled denim jeans ribbon will be launched at the company's upcoming 2010 spring/summer project. All proceeds from the recycled denim jeans ribbon will go to support children suffering from chronic and life threatening rare illnesses.

"When we first heard about the Global Genes Project and the idea behind a denim jeans ribbon to represent millions of children afflicted by rare diseases, the story touched our hearts," said Tom Cards, CEO, reco® jeans. "It's astounding how many children are affected by rare diseases and how little the general public knows of this community. We are proud to be part of this global awareness initiative, and we hope others will join us in giving back to kids and families facing rare diseases."

reco® jeans eco-friendly recycled denim fabric has been approved and certified by the Hong Kong Green Council and is pending certification from a number of U.S. organizations. The company's fabric is comprised of mixed materials collected from scraps of cut and sew pieces that normally would end up in landfills. reco® jeans takes the idea behind green clothing to a new level and the company's fabric is currently being studied by a prestigious University as an option to eliminate waste within the garment industry.

"reco® jeans has always been an innovative company with the goal of creating a healthier planet," said Nicole Boice, founder, Global Genes Project. "We are thrilled reco® jeans is joining forces with us to help find treatments and cures for rare diseases and we look forward to seeing the unique twist they will add to the blue ribbon using their recycled denim material."

To further raise funds and awareness in the fight against rare diseases, reco® jeans is organizing a charity event to support the Global Genes Project.  Company employees will also be wearing and distributing handmade denim jeans ribbons to the public leading up to World Rare Disease Day on February 28, 2010. World Rare Disease Day is an event designed to call attention to the global public health issues associated with the 7000 rare diseases affecting nearly 30 million Americans and countless others worldwide.

For those interested in attending or participating in the reco® jeans charity event, please visit www.recojeans.com. For more information about reco® jeans or its efforts to support children with rare diseases, please contact natalie@recojeans.com.

SOURCE reco jeans

Back to top

RELATED LINKS
http://www.recojeans.com

'/>"/>

SOURCE reco jeans
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. AUDIO from Medialink and Kelloggs: The Jeans Dont Lie
2. Old London Launches Skinny Jeans Contest
3. VIDEO from Medialink and Kelloggs: Its All in the Jeans
4. Celebrity Signed Jeans Live at Auction During Baby & Tween Celebration LA
5. Kim Kardashian Says Real Women Keep Their Curves With Fit In Your Jeans By Friday
6. DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Childrens Research Hospitals Thanks and Giving(R) Campaign
7. HealthFitness CEO Supports Move Toward Cultural Shift, and Science-Based Health Management Programming
8. Diageo Supports First Ever National We Dont Serve Teens Week
9. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
10. Discovery supports theory of Alzheimers disease as form of diabetes
11. Study Supports Change to Prostate Cancer Biopsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: